Genezen, a cell and gene therapy Contract Development and Manufacturing Organization (CDMO) specializing in lentiviral and retroviral vector manufacturing, has appointed Jeff Whitmore as chief commercial officer (CCO).   With a career in biotechnology spanning over 25 years, Whitmore joins Genezen from mRNA Therapeutic CDMO, TriLink BioTechnologies, part of Maravai LifeSciences, where he most recently served as vice president of Commercial Operations and had responsibility for commercial expan...